Name
                                    Gene Therapy Breakout: Gene Therapy 101
                                        Date & Time
                                    Tuesday, October 18, 2022, 10:00 AM - 10:45 AM
                                        Location Name
                                    Melrose 3
                                        Description
                                    A rapidly growing number of new drugs and vaccines contain genetically modified DNA or RNA, with many new products entering Phase 3 clinical trials and some receiving FDA marketing approval.
This breakout session will provide an overview of the technology behind viral vectors, CAR-T cells, mRNA vaccines, and related advanced therapies. A brief discussion of special regulatory considerations for this research will be included.
Speakers
                                    
                                
Learning Objectives
                                    - Compare Gene Therapy/Gene Editing, Autologous / Allogeneic, and Ex Vivo / In Vivo approaches.
- Describe how cell and gene therapy products treat disease.
- Review examples of FDA-approved and investigational categories of cell and gene therapy products
This Module is Eligible for
                                    ACRP CE Points, CCB Credits, CLE Credits, CME Credits, CNE Credits
                                        ACRP CE Points
                                    0.75